In what could be very good news for the immunocompromised, an antibody cocktail tested at the University of Virginia School
Read more
Home »
Regeneron says COVID antibody treatment protects for at least 8 months
A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic COVID by more than 80 percent up
Read more
Vaccinated children induced significantly higher antibody titers than naturally infected children
A recent preprint available on the bioRxiv* preprint server discusses the antibody response to the nucleic acid vaccines against the
Read more
PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend
PerkinElmer, Inc. (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced it has completed its
Read more
Third vaccine dose reduces transmission and severe COVID-19 nationwide in Israel
Following the successful administration of two doses of the Pfizer BNT162b2 vaccine to most eligible adults in Israel, the country
Read more
UVA research quantifies the antibody response generated by Pfizer and Moderna COVID vaccines
New research from the University of Virginia School of Medicine quantifies the antibody response generated by the Pfizer and Moderna
Read more
COVID-19 booster shot in autumn will effectively protect against existing and future variants
Scientists at the University of Nottingham have confirmed that an autumn 'booster' dose of a Covid-19 vaccine will be an
Read more
Novel monoclonal antibody could pave way for future COVID-19 treatments and vaccines
Researchers in the United States have shown that targeting the N-terminal domain (NTD) of the severe acute respiratory syndrome coronavirus
Read more
Potent antibody responses to BNT162b2 COVID-19 vaccine among Japanese healthcare workers
The Pfizer-BioNTech mRNA vaccine against COVID-19 (BNT162b2) has demonstrated great short-term efficacy in lowering the incidence of severe acute respiratory
Read more
How antibody production in the lungs can determine severe respiratory infections
A majority of individuals who experience certain respiratory infections like the novel coronavirus disease 2019 (COVID-19) may only experience mild
Read more